Results 191 to 200 of about 533,812 (257)

REGENECYTE cord blood cell therapy in post-COVID syndrome: a phase IIa randomized, placebo-controlled trial. [PDF]

open access: yesEClinicalMedicine
Huang YW   +7 more
europepmc   +1 more source

Mast Cells in Acute COVID‐19 Patients

open access: yes
Allergy, EarlyView.
Ilan Zaffran   +8 more
wiley   +1 more source

Day‐30 IL1RL1, CXCL9 and REG3α are prognostic for survival after mismatched unrelated donor transplantation

open access: yesBritish Journal of Haematology, EarlyView.
Summary While plasma‐derived proteins have emerged as potential biomarkers for prognosis after haematopoietic stem cell transplantation (HSCT), there are insufficient data assessing if established proteins interleukin 1 receptor‐like 1 (IL1RL1), chemokine ligand 9 (CXCL9) and regenerating islet‐derived 3‐α (REG3α) retain their utility in the mismatched
Trent Wang   +8 more
wiley   +1 more source

Persistent sleep symptoms in post-COVID syndrome: a Brazilian prospective clinical study. [PDF]

open access: yesArq Neuropsiquiatr
Moura AEF   +7 more
europepmc   +1 more source

Correlations Between Oxygen Consumption, Ventilatory Mechanics, and Lung Ultrasound in Individuals with Post-COVID Syndrome. [PDF]

open access: yesInt J Environ Res Public Health
Oliveira JGM   +9 more
europepmc   +1 more source

A SWOT Analysis of Three Programmes for Persons With Intellectual Disabilities in Higher Education Settings in Chile, Ireland and Australia

open access: yesBritish Journal of Learning Disabilities, EarlyView.
ABSTRACT Background Educational access is key in empowering persons living with intellectual disabilities. Nevertheless, internationally, Persons with Intellectual Disabilities continue to experience marginalization and discrimination in accessing higher education.
Denise De Souza   +8 more
wiley   +1 more source

The association between Post-COVID syndrome and self-stigma among the adult Israeli population during the COVID-19 pandemic. [PDF]

open access: yesBMC Public Health
Polovin T   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy